PBYI Q1 2017 Earnings — Puma Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

PBYIPuma Biotechnology, Inc.

$299M

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$73M

Net Income

-$73M

EPS (Diluted)

$-1.97

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$36M

Stock-Based Comp.

$30M

Balance Sheet

Total Assets

$217M

Total Liabilities

$49M

Stockholders' Equity

$167M

Cash & Equivalents

$105M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$73M	-$71M	-2.7%
Net Income	-$73M	-$71M	-2.7%